You are here: Industry Insights > stada

News List

STADA to acquire 16 consumer healthcare brands from Sanofi pharmaceutical-technology
June 30, 2021
Germany-based STADA has agreed to acquire 16 consumer healthcare brands from Sanofi in 13 European markets, including Germany, France, Poland, Italy and Spain.
STADA agrees to buy 15 consumer healthcare brands from GSK pharmaceutical-technology
March 04, 2020
Germany-based STADA has agreed to buy a portfolio of 15 consumer healthcare brands from GlaxoSmithKline (GSK) in European countries, including Germany, France, Poland, Italy, Russia, Spain and Switzerland.
Does Stada need Takeda's for-sale European drugs? CEO says no fiercepharma
August 15, 2019
If German generics maker Stada is looking for a large deal, Takeda’s reportedly for-sale European drugs could be a good target. But to hear Stada's CEO tell it, the company has plenty of choices.
STADA to hire hundreds of employees firstwordpharma
March 20, 2019
Following the takeover by financial investors, the pharmaceutical manufacturer Stada intends to expand its business considerably.
Stada's boards recommend shareholders accept Bain, Cinven's improved takeover offer firstwordpharma
July 26, 2017
Stada Arzneimittel's executive board and supervisory board recommended that shareholders accept an improved takeover offer from private equity firms Bain Capital and Cinven, the drugmaker said Tuesday.
Stada CEO and CFO tumble in takeover turmoil pharmafile
July 05, 2017
Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’.
Stada gives suitors more time to raise bids regarding potential takeover firstwordpharma
March 17, 2017
Stada Arzneimittel confirmed Thursday that it has "postponed" planned presentations to bidding groups, which reportedly include two competing private equity consortia that have made offers worth about 3.7 billion euros ($4 billion).
Stada encourages bidding war, with figure of €3.5 billion mooted pharmafile
February 16, 2017
Stada has received two offers for takeover, with one estimated to be €3.5 billion.
Stada receives two takeover proposals, including a 3.6-billion euros bid from Cinven firstwordpharma
February 13, 2017
Stada Arzneimittel confirmed Sunday that it received two non-binding takeover proposals, including a 3.6-billion euros ($3.8 billion) bid from private equity group Cinven at 56 euros ($59.50) per share, representing a 15-percent premium to Stada's closing